InsidersTradesSigma
Track the Cyclopharm Limited stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, Cyclopharm Limited has recorded 3 public disclosures. Market capitalisation: €65.4m. The latest transaction was reported on 8 May 2026 (Other). Among the most active insiders: Kevin Michael John Barrow. Every trade is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,570 of 29,064 companies
9.0
score / 100
Value8
Quality10
FCF yld-30%
Earn yld-27%
EV/EBITDA·
ROE-54%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 May 2026
Declarations3 total
ShareASXISIN AU000000CYC5ASX:2924-03088317-2A1671244
ShareASXISIN AU000000CYC5ASX:2924-03088315-2A1671243
ShareASXISIN AU000000CYC5ASX:2924-03086079-2A1669768
3 of 3 declarations
关于 Cyclopharm Limited
Cyclopharm Limited 是一家专注于放射性药物产品开发和商业化的公司。该公司在 XASX 市场上市。